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Aim: Early breast cancer detection is important for intervention and prognosis. 
Advances in treatment and outcome require diagnostic tools with highly positive 
predictive value. Purpose: To study the potential role of quantitative MRI (qMRI) 
using T1/T2 ratios to differentiate benign from malignant breast lesions. Methods: 
A cross-sectional study of 69 women with 69 known or suspicious breast lesions 
were scanned with mixed-turbo spin echo pulse sequence. Patients were grouped 
according to histopathological assessment of disease stage: untreated malignant 
tumor, treated malignancy and benign disease. Results & Discussion: Elevated T1/T2 
means were observed for biopsy-proven malignant lesions and for malignant lesions 
treated prior to qMRI with chemotherapy and/or radiation, as compared with benign 
lesions. The qMRI-obtained T1/T2 ratios correlated with histopathology. Analysis 
revealed correlation between elevated T1/T2 ratio and disease stage. This could 
provide valuable complementary information on tissue properties as an additional 
diagnostic tool.
Lay abstract: Early detection is important for successful intervention in breast cancer. 
We studied the potential role of quantitative MRI (qMRI) using T1/T2 ratios to 
differentiate benign from malignant breast lesions. Sixty nine women with breast 
lesions were scanned with qMRI. Elevated ratios were observed for biopsy-proven 
malignant lesions and for malignant lesions that were treated prior to qMRI with 
chemotherapy and/or radiation, as compared with benign lesions. With further 
studies, this approach could provide valuable information concerning tissue properties 
in addition to established breast imaging sequences and be an additional diagnostic 
tool.
First draft submitted: 7 September 2016; Accepted for publication: 20 March 2017; 
Published online: 2 May 2017
Keywords:  breast imaging • development of potential biomarker for evaluation of breast 
disease • magnetic resonance imaging • quantitative magnetic resonance imaging
Background
Breast cancer is the most common cancer 
among women, except for skin cancers [1]. 
About one in eight (12%) women in the 
USA will develop invasive breast cancer dur-
ing their lifetime [1]. According to American 
Cancer Society, about 246,660 new cases 
of invasive breast cancer were diagnosed in 
women in 2016, and 61,000 new cases of car-
cinoma in situ will be diagnosed (carcinoma 
in situ is noninvasive and is the earliest form 
of breast cancer [1].
Early detection is important for success-
ful intervention and improved prognosis. 
Advances in the treatment and outcome of 
patients with breast cancer require the devel-
opment of diagnostic tools with highly  positive 
predictive value.
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Imaging modalities such as mammography, ultraso-
nography and MRI are routinely used to identify and 
characterize breast lesions [2,3]. Mammography, for 
all its limits, is still the only test proven to decrease 
mortality in multiple, randomized, controlled trials 
and through experience with population-based screen-
ing [4].
There are known limitations of mammography, 
especially in women with extremely dense breast tissue 
and inconsistent results when this technique is utilized 
in detecting small cancers before they are palpable that 
can improve survival, as well as treatment options [5].
MRI is recognized as a supplement to mammogra-
phy in the visualization and characterization of breast 
lesions and over the last decade, MRI was widely 
adopted for assessment of breast disease [6–9].
Kuhl summarized current guidelines of breast MRI 
in 2007 review paper and emphasized that compared 
with mammography and breast ultrasonography, con-
trast-enhanced MRI is a breast imaging technique that 
offers not only information on lesion cross-sectional 
morphology, but also adds information on functional 
lesion features such as tissue perfusion and enhance-
ment kinetics [10]. Kuhl et al. refined management rec-
ommendations for women with increased familial risk 
of breast cancer in a prospective multicenter cohort 
study based on utilization of MRI [11].
Breast MRI still remains an active research field [12–
16]. Although the gamut of MRI techniques for breast 
cancer diagnosis reported in the scientific literature 
is very rich, surprisingly; quantitative MRI (qMRI) 
relaxometry of breast lesions has received much less 
attention. Early breast MRI work by Medina et al. 
showed that calculated values of the ratio T1/T2 
provided improved discrimination of fibroadenomas 
from adenocarcinomas (p < 0.05) [17]. This ratio has 
also been found useful for discriminating benign from 
malignant liver lesions [18].
The need for establishing imaging biomarkers of 
breast cancer conducive to reducing the need for unnec-
essary biopsies cannot be overstated. Discriminating 
breast malignancy by measuring the ratio of the longi-
tudinal to the transverse MRI relation times constitutes 
a noninvasive approach that is novel to our knowledge; 
reports in the literature on this subject are nonexistent.
The purpose of this work was to measure the T1/T2 
ratios of a variety of breast lesions and to correlate with 
histopathological findings with the goal of increasing 
the diagnostic power of MRI.
Materials & methods
Study design
This was a cross-sectional study in which any patients 
scheduled to undergo MRI were asked to undergo an 
additional imaging sequence (mixed turbo spin echo 
(mixed-TSE)) following the acquisition of the standard 
conventional imaging. There was no randomization 
applied. This study was approved by Boston Univer-
sity Institutional Review Board. Informed consent was 
obtained from each patient prior to any study proce-
dures being performed in compliance with Declaration 
of Helsinki.
Study population
Eighty-four women of different ethnicities with 
known lesions who were scheduled for breast MRI at 
Boston Medical Center Radiology Department and 
met the eligibility criteria listed below were invited 
to participate in this study. Inclusion criteria called 
for any woman older than 18 years of age at the time 
of consent who was scheduled to undergo a breast 
MRI for a known breast cancer or suspicious breast 
lesions. Patients who were pregnant or lactating were 
excluded from participation as the accompanying hor-
monal changes might confound the ability to accu-
rately detect malignancy [19]. Other exclusion criteria 
included claustrophobia, presence of metallic foreign 
body or orbital metal, prior reaction or allergy to 
intravenous gadolinium, renal insufficiency or failure, 
renal transplant within the past 3 months and inabil-
ity to provide written informed consent. Consent was 
obtained by the clinical research associate for the extra 
sequence, which was performed at the end of the rou-
tine MRI examinations.
Out of the total 84 women scheduled for breast 
MRI in the study time frame, who initially consented 
for this study, 69 subjects with 69 known lesions suc-
cessfully completed all study procedures (82.14% 
participation rate). Fifteen women did not participate 
due to the following reasons: four patients changed 
their mind and withdrew consent after it was initially 
obtained, five cancellations for scheduled conven-
tional breast MRI occurred, two declined to undergo 
additional research qMRI sequence after completing 
routine care sequence, three patients were uncomfort-
able laying down in the scanner and one developed a 
headache.
Our primary objective was to assess whether there is 
a correlation between T1/T2 ratio obtained by qMRI 
and the assigned level of suspicion based on the clinical 
diagnosis. Results were correlated with histopathology 
and clinical staging (stage 0, 1, 2, 3 or 4 or benign). 
The study cohort was divided into three groups as 
f ollows:
•	 Group 1: primary cancer as defined by no prior 
treatment based on medical history and cancer 
diagnosis confirmed by histopathology analysis.
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•	 Group 2: cancer post treatment as defined by any 
previously treated cancer patient who has under-
gone therapy with radiation, chemotherapy or some 
combination.
•	 Group 3: benign as defined by no histopathologic 
evidence of malignancy.
The secondary objective was to compare findings of 
conventional MRI to qMRI results.
Early rapid enhancement after gadolinium admin-
istration on conventional MRI was examined in cor-
relation with T1/T2 ratio obtained by qMRI in order 
investigate their potential complementary use.
Standard protocol including injection
Images were acquired with a 1.5-T superconduct-
ing MRI scanner (Achieva Philips Medical System, 
Cleveland, OH, USA) and 7-channel breast array 
(Invivo, FL, USA). Our routine breast imaging proto-
col includes the following imaging sequences: axial T1 
TSE, axial STIR and axial dynamic T1 high resolu-
tion isotropic volumetric excitation sequences of both 
breasts. The volumetric sequences were optimized for 
a temporal resolution of between 60 and 75 s. The 
dynamic images were acquired immediately after the 
intravenous administration of gadopentetate dimeglu-
mine (Magnevist, 0.2 ml/kg, Bayer Healthcare, NJ, 
Figure 1. Demographic variables assessment. (A) Study population assessment by race. (B) Menopausal status of 
study population. (C) Age of study subjects. Study population consisted of 32% of black, 42% white, 21% Hispanic 
1% Asian and 4 % Arabic women (A). Seventy four percent of women that were included in this study were still 
menstruating and 26% were postmenopausal (B). Thirteen percent of women were less than 40 years old, 59% of 
subjects were older than 40 and 28% were older than 60 years (C). 
21%
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USA) and intravenous saline flush (20 cc, rate 2 cc/s). 
At least four time points were obtained in the dynamic 
series for kinetic analysis using a CADstream (Merge 
Healthcare, IL, USA) system.
qMRI research sequence
Mixed turbo spin echo is a multislice 2D pulse 
sequence that was applied in the coronal plane pro-
viding full bilateral breast coverage with null inter-
slice gap: 0.82 × 0.82 × 3 mm3 voxel size. Mixed-TSE 
combines the principles of T1-weighting by inversion 
recovery and T2-weighting by dual-TSE sampling into 
a single mixed MRI acquisition. The mixed-TSE pulse 
sequence has two echo times (TEs) = 7.1/100 ms, two 
inversion times (TIs) = 700/5033 ms, an echo train 
length (ETL) = 18 and repetition time (TR) = 10,066 
ms. As per protocol this research scan was obtained 
5–6 min post-gadolinium injection. The length of 
qMRI sequence can vary between 5 and 12 min due to 
amount of time needed to scan the breast tissue which 
can vary slightly due to actual difference in breast size 
of individual subjects.
Image processing & data analysis
Images were Digital Imaging and Communications 
in Medicine (DICOM) transferred to our image pro-
cessing laboratory and prepared for further processing 
in MathCAD (PTC, MA, USA). Self-coregistered 
T1 and T2 maps were generated with formulas as 
described in prior work [20] and used as input for a 
T1/T2 ratio algorithm that avoids singularities with a 
pixel-wise Boolean conditional statement. For all the 
subjects, the lesions were identified by an experienced 
radiologist, with 7 years of experience in breast imag-
ing, which had access only to conventional MRI data 
and was blinded to histopathology findings. In every 
case, rectangular regions of interest (ROI) were placed 
within the lesion, as identified by the radiologist. Glan-
dular tissues were analyzed bilaterally by qMRI as an 
internal control for each subject to verify that changes 
seen in ROIs on qMRI are attributed to the disease 
process occurring in the breast tissues analyzed. Con-
tralateral breasts were assessed by qMRI to examine 
bilateral involvement.
The person performing qMRI analysis was blinded 
to histopathology and had no access to medical records 
in an effort to avoid selection and measurement bias. 
Pathology results (stage and/or grade of tumor) were 
obtained for each subject based on available data includ-
ing prior surgery or image-guided biopsy,  allowing 
 correlation between pathology and qMRI data.
Demographic information, current and past hor-
monal use, personal history of breast cancer, family 
history of cancer, menopausal status and day of men-
strual cycle were also collected based on comprehensive 
review of medical records and patient interviews.
Statistical data analysis
The data obtained from 41 subjects with 46 lesions 
were analyzed using SAS program, version V 9.1 (SAS 
Institute Inc., NC, USA). In order to meet our pri-
mary objective, the nonparametric analysis was used 
and correlation between T1/T2 ratios and the grade 
assigned based on clinical diagnosis was examined.
We performed stratified data analysis and controlled 
for multiple variables (age, race, family history of 
cancer, hormonal status such as pre-, peri- and post- 
hormone replacement or contraceptive use and day 
of menstrual cycle) as potential confounders by using 
multiple linear regression models or stratified  Mantel–
Haenszel chi-square analysis as appropriate.
Also, chi-square test was performed to examine 
correlation between higher T1/T2 ratio obtained by 
qMRI and early rapid enhancement after gadolinium 
Figure 2. T1/T2 ratio qMRI maps of analyzed lesions. 
Representative T1/T2 ratio qMRI maps demonstrated 
distinctive appearance that corresponded with 
pathology findings. White arrowheads point to 
pathology in the breast tissue. (A) Invasive ductal 
carcinoma in situ (DCIS), Stage 1. Several ring-
enhancing lesions around lumpectomy site in right 
breast may represent residual tumor. (B) Invasive 
lobular carcinoma, Stage 2A status post-lumpectomy, 
radiotherapy, current Tamoxifen therapy. (C) 
Fibroadenoma, benign. White arrowheads indicated 
benign lesions in the breast tissue. (D) Invasive ductal 
carcinoma, Stage 1A, newly diagnosed, no prior 
treatment.
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administration on conventional MRI.
Results
The qMRI analysis was successfully performed in n 
= 69 subjects with 69 lesions. The study population 
demographic variables are presented in Figure 1A–C. 
All 69 analyzed lesions were categorized as benign or 
malignant based on pathology findings obtained by 
image-guided or open surgical biopsies. Representative 
T1/T2 ratio maps with the positioning of rectangular 
ROIs over lesions are shown in Figure 2.
Descriptive statistical analysis showed different 
means for the three groups that were analyzed. The 
T1/T2 ratio means were 8.20 ± 1.05 (n = 12) for 
biopsy-proven malignant lesions, 6.55 ± 0.63 (n = 28) 
for malignant lesions that were treated prior to qMRI 
with chemotherapy and/or radiation and 4.1 ± 0.43 (n 
= 29) for benign lesion as shown in Figure 3.
Nonparametric analysis correlating T1/T2 ratio and 
the tumor grade was performed. The Wilcoxon scores 
for T1/T2 ratio were assigned based on rank sums that 
were performed for each group. The mean scores were 
54.92 for Group 1 (n = 12, primary cancer), 51.82 for 
Group 2 (n = 28, cancer post-treatment with chemo-
therapy and/or radiation) and 30.79 for Group 3 (n = 
29, benign lesions included 12 subjects with cysts and 
17 with fibroadenoma) respectively. The differences 
found among these three groups regarding T1/T2 ratio 
were statistically significant (p = 0.0002) as shown in 
Figure 4.
These results were reflective of stratification that 
was performed during data analysis and adjustments 
were made for confounding variables such as age, race, 
postmenopausal status, hormonal contraceptives use 
and personal and family cancer history. Specifically, 
we controlled these confounding variables by using 
multiple linear regression models or stratified Mantel–
Haenszel Chi-square analysis as appropriate.
Chi-square test showed a strong correlation between 
higher T1/T2 ratio and a primary cancer group 
(Group 1) compared with other groups, and the results 
were statistically significant (p = 0.0335). In addition, 
the higher stage of cancer determined by histopathol-
ogy analysis was also strongly associated with higher 
T1/T2 ratio (p = 0.0093).
We analyzed contralateral breast and assessed T1/
T2 ratios of glandular tissue as a control sample in all 
study groups (Figure 5A–F). Since all the measurements 
were performed post-gadolinium administration, we 
wanted to be certain that the observed differences in 
T1/T2 ratio attained by qMRI in examined groups 
were attributed to pathological changes in the breast 
tissue and/or in response to treatment. The distri-
bution of T1/T2 ratios for cancer group with corre-
sponding glandular controls and contralateral breast 
 assessments are presented in Figure 5A & B.
Figure 3. T1/T2 ratios obtained by qMRI for different breast lesions. The mean scores obtained by descriptive 
statistical analysis were 8.20 ±1.05 for Group 1 (n = 12, primary cancer), 6.55 ± 0.63 for Group 2 (n = 28, cancer 
post-treatment with chemotherapy and/or radiation) and 4.1 ± 0.43 for Group 3 (n = 29, benign lesions included 
12 subjects with cysts and 17 with fibroadenoma), respectively.
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Figure 4. The mean values of Wilcoxon scores, correlating T1/T2 ratio and the grade of tumor by histopathology, 
obtained by non-parametric analysis. These scores were 54.92 for Group 1 (n = 12, primary cancer), 51.82 for 
Group 2 (n = 28, cancer post-treatment with chemotherapy and/or radiation) and 30.79 for Group 3 (n = 29, 
benign lesions included 12 subjects with cysts and 17 with fibroadenoma), respectively.
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The T1/T2 ratio means were 8.20 ± 1.05 (n = 12) 
for biopsy-proven malignant lesions as compared with 
glandular tissue control in the same breast of 2.30 ± 
0.62 (n = 12) (Figure 5A). According to performed Stu-
dent’s t-test statistical analysis, the differences in T1/
T2 ratios observed between malignant and glandular 
tissues were highly statistically significant (p = 3.06652 
× 10-6). Fewer subjects were assessed for contralateral 
breast; in four subjects only one breast was scanned by 
MRI due to clinical indication and/or prior mastec-
tomy (n = 8) (Figure 5B). The mean T1/T2 ratio for 
contralateral breast was 5.18 ± 2.74 (n = 8) and 2.39 ± 
1.03 (n = 8) for glandular tissue control sample of cor-
responding breast.
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Figure 5. Contralateral breast and glandular control tissue assessments in primary cancer (A & B), post-treatment 
group (C & D) and benign lesions (E & F) by qMRI. In primary cancer group fewer subjects were assessed for 
contralateral breast since in 4 subjects (samples 1, 2, 3, and 8) only one breast was scanned by MRI due to clinical 
indication and/or prior mastectomy (n = 8) (B). Elevated T1/T2 ratios were detected in three subjects (samples 3 
– known bilateral malignancy, 6 and 23 – newly detected) of contralateral breast in post-treatment group (Figure 
5D, labelled respectively by “*”, “?”), both were confirmed for malignancy by histopathology analysis.
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Furthermore, T1/T2 ratio means were 6.55 ± 0.63 
(n = 28) for malignant lesions that were treated prior 
to qMRI with chemotherapy and/or radiation as com-
pared with glandular tissue control in the same breast 
of 2.99 ± 0.26 (n = 28) (Figure 5C & D). Observed dif-
ferences in T1/T2 ratios between malignant lesions 
post-treatment and glandular tissue control were sta-
tistically significant (p = 3.5385 × 10-13). In post-treat-
ment group, the mean T1/T2 ratio for contralateral 
breast of was 3.48 ± 0.82 (n = 28) and 1.82 ± 0.22 (n = 
28) for glandular tissue control sample of correspond-
ing breast.
Distribution of T1/T2 ratios for benign lesions is 
shown in Figure 5E & F. The mean T1/T2 ratios were 
4.1 ± 0.43 (n = 29) for benign lesion and 1.76 ± 0.35 
(n = 29) for glandular tissue control, respectively. The 
difference in T1/T2 values found between benign 
lesions and control were statistically significant (p = 
6.02714 × 10-9). In this group, the mean T1/T2 ratio 
for contralateral breast was 4.38 ± 1.52 (n = 29) and 
1.87 ± 0.21 (n = 29) for glandular tissue control sam-
ple of corresponding breast (detailed distribution of 
T1/T2 ratios is shown in Figure 5E).
Overall, elevated T1/T2 ratios detected in primary 
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cancer and post-treatment group were consistently 
higher than the ones observed in glandular control tis-
sues, indicating that differences in T1/T2 ratio between 
examined groups, obtained post-gadolinium adminis-
tration, were attributed to pathological changes in duc-
tal or lobular breast tissues. In addition, elevated T1/
T2 ratios were detected in two samples of contralateral 
breast in post-treatment group (Figure 5D), both were 
confirmed for malignancy by histopathology analysis.
In order to explore potential complimentary use of 
qMRI and conventional breast MRI, we examined 
the relationship between findings of those two breast 
imaging techniques. Forty images with confirmed 
malignancy by histopathology analysis (primary can-
cer n = 12, post-treatment cancer n = 28) were ana-
lyzed by experienced breast imaging radiologist who 
was blinded to pathology results. We observed that 
early rapid enhancement after gadolinium administra-
tion on conventional MRI did correlate with elevated 
T1/T2 ratio (p = 0.0007).
Discussion
We applied qMRI relaxometry of T1/T2 ratio to study 
breast lesions with different histopathology. This tech-
nique allowed mapping the longitudinal-to-transverse 
relaxation times ratio T1/T2 of benign and malignant 
breast lesions. It provided a quantitative result and 
produced high quality image on T1, T2 and T1/T2 
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maps, as tested on 69 female subjects with 69 known 
or suspected lesions. Histopathologic analysis was per-
formed for all lesions per standard of care. We found 
that there was a statistically significant difference 
in the T1/T2 ratios of benign and malignant breast 
lesions.
Furthermore, we found statistically significant cor-
relation between higher T1/T2 ratio and higher stage 
of breast cancer determined by histopathology. Since 
histopathology is the current standard for diagnosis of 
breast cancer, this correlation is an important observa-
tion as this new qMRI technique may have a role in 
pre-operative counseling of patients with a new diag-
nosis of breast cancer.
In addition, early rapid enhancement after gado-
linium administration on conventional MRI did cor-
relate with higher T1/T2 ratio obtained by qMRI (p 
= 0.0007). Therefore, there is a potential for comple-
mentary use of those two breast imaging techniques in 
the future.
Over the past 10 years, MRI of the breast has gained 
increasing importance in the field of breast imaging. A 
variety of MRI-based techniques are currently utilized, 
as summarized below.
First, scientific evidence provided by a considerable 
number of large-scale trials had confirmed that quan-
titative measures obtained by MRI using apparent 
diffusion coefficient as a technique for breast imaging 
demonstrated unsurpassed sensitivity for primary and 
recurrent breast cancer [13–15].
Second, Eliata et al. had used in multicenter trials a 
quantitative dynamic contrast enhanced T1 relaxome-
try [21]. They reported a high sensitivity (around 95%) 
but lower specificity that varied in a wide range (from 
45 to 90%) for characterization of breast tumors [20].
In addition, some scientists utilized dynamic 
T1-weighted [13,22] and T2-weighted [23,24] MRI imag-
ing for diagnostic assessments of breast tissue or for 
monitoring response of primary breast cancer to che-
motherapy. It was shown that in dynamic breast MR 
imaging, invasive breast cancers were detectable due to 
their strong enhancement (signal intensity increase on 
T1-weighted images) that peaked early after contrast 
material injection [13,22].
It was reported by Kuhl et al. that in a contrast-
enhancing breast lesion, careful analysis of T2-weighted 
TSE images can improve differential diagnosis [23]. It 
was possible to distinguish between fibroadenomas 
and breast cancers on those T2-weighted images [23]. 
However, results for specificity and sensitivity var-
ied significantly between young and older (over 50 
years old) patients [23]. Therefore, the accuracy of this 
breast imaging technique is dependent on age [23]. 
Bartella et al. reported that substantial percentage 
(24%) of invasive cancers had high or intermediate T2 
 signal [24].
In summary, it still remains challenging to discrimi-
nate malignant lesions from normal or benign struc-
tures with MRI. Although listed above techniques 
provide useful tools for breast cancer diagnosis with 
high sensitivity (90–95%), a highly specific imaging 
biomarker is needed [13–24].
Early work by Medina et al. used T1 and T2 relax-
ation times to investigate the ability of NMR spectros-
copy to distinguish normal, diseased non-neoplastic 
and neoplastic human breast tissues [17]. The results 
indicated that NMR relaxation times could distinguish 
between the mean values of breast neoplasms and other 
diseased or normal tissues, with p-values <0.001 [17]. 
Given a single sample, the probability of classifying it 
as non-neoplastic or carcinoma could be accomplished 
with 85% confidence. Medina et al. emphasized that 
for human breast tissues, the relaxation time T2 may 
be more discriminating than T1 [17]. Medina et al. sug-
gested that the T1/T2 ratio could be useful for char-
acterizing breast dysplasias and neoplasms. Further-
more, this T1/T2 ratio has also been found useful for 
discriminating benign from malignant liver lesions by 
Farraher et al. [18].
In our study, we found strong correlation between 
findings of contrast enhanced MRI and our qMRI 
results. In addition, the qMRI offered a quantitative 
approach to the assessment of breast lesions, whereas 
conventional MRI only provides qualitative informa-
tion. Furthermore, elevated T1/T2 ratios have been 
observed in hepatocellular carcinomas previously by 
Farraher et al. [18].
Also, qMRI of T1/T2 could be utilized in ques-
tionable cases for evaluation of patients with abnor-
mal hyperplasia to non-invasive and low-grade inva-
sive carcinoma in order to distinguish better among 
these borderline conditions. It may be potentially use-
ful technique in women with questionable mammo-
graphic and clinical findings, in patients with previous 
breast surgery to better distinguish post-surgical scar 
from recurrent carcinoma and also in women with very 
dense breasts or to evaluate small lesions.
Further prospective, larger studies are needed that 
will enable use of receiver operator curves, obtained by 
qMRI technique for breast tissues. These studies will 
provide additional data for sensitivity and specificity 
analysis to establish diagnostic value of qMRI for char-
acterization of breast lesions.
Limitations of the study
One potential limitation stems from acquiring images 
after gadolinium injection, which affects the relaxation 
times. All mixed-TSE scans were run at approximately 
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5–6 min after the gadolinium was initially injected and 
this time interval was kept constant among subjects in 
order to minimize potential relaxometric inconsisten-
cies among subjects. Because of the long duration of 
the MRI examination and in consideration of research 
subjects comfort, it was decided for this pilot study to 
run the research scan last, so to give subjects a possibil-
ity to opt in/out in case of high discomfort.
The encouraging diagnostic findings of this post-
gadolinium study could serve as a motivation to 
explore further the value of the T1/T2 ratio pre-con-
trast administration. Further pre-gadolinium adminis-
tration studies will be necessary to fully establish the 
clinical value of this qMRI parameter. Nevertheless, 
from a pragmatic point of view, the post-gadolinium 
T1/T2 ratio measured consistently 5–6 min post-con-
trast injection in all subjects, appears to be a promis-
ing diagnostic tool for evaluation of breast disease and 
could potentially lead to the reduction of breast biop-
sies.
Generalizability of the present results is limited to 
post-menopausal women and women who are between 
days 5 and 10 of menstrual cycle, since we excluded 
women that were in a different part of their menstrual 
cycle in order to avoid hormonal fluctuations and 
decrease variability of MRI results. In addition, the 
Asian population was under-represented (only 2% of 
the studied cohort). Therefore, the results of the study 
could only be generalized to Caucasian, Black and His-
panic women. Additional studies are needed to assess 
this technique in other ethnic groups.
Since this was a cross-sectional study, the post-
treatment cancer group was not homogeneous. Specifi-
cally, based on inherited limitation of the study design, 
we could not avoid including subjects at the different 
time points of their treatment (e.g., variable cycles of 
chemotherapy were performed by individual subjects 
prior to qMRI assessment) and/or subjects on differ-
ent treatment regimens (e.g., different combinations of 
chemotherapy and/or radiotherapy).
Also, in the current study, different histopathologi-
cal types of breast malignancy (e.g., ductal and lobular 
carcinoma) were combined due to the relatively small 
numbers for lobular carcinoma. We only examined 
two subjects with lobular carcinoma out of 69 assessed 
subjects in which majority of cases were with ductal 
carcinoma. It did not permit an analysis of whether 
invasive ductal or lobular cancers exhibit different 
quantitative properties on qMRI. This issue needs to 
be explored in future studies.
Conclusion & future perspective
In summary, we found a significant difference in 
the T1/T2 ratios of benign and malignant breast 
lesions. In addition, a significant correlation betw-
een elevated T1/T2 ratios and more advanced stage 
of breast cancer confirmed by histopathology was 
observed.
Combining quantitative information of different 
tissue properties such as T1/T2 ratio may provide a 
useful additional diagnostic tool for breast cancer. This 
could potentially translate into establishing imaging 
biomarkers of breast cancer and reduction in the num-
ber of benign breast biopsies.
This qMRI approach may provide valuable comple-
mentary information to established breast imaging 
sequence which can possibly translate into improved 
diagnosis of breast cancer.
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Executive summary
Background
•	 Breast cancer is one of the most common cancers among women. Early detection is important for successful 
intervention and improved prognosis. Advances in the treatment and outcome of patients with breast cancer 
require the development of diagnostic tools with highy positive predictive value.
•	 Imaging modalities such as mammography, ultrasonography and MRI are routinely used to identify and 
characterize breast lesions. MRI is recognized as a supplement to mammography in the visualization and 
characterization of breast lesions. The purpose of this work was to measure the T1/T2 ratio of a variety of 
breast lesions and to correlate with histopathological findings with the goal of increasing the diagnostic 
power of MRI.
Materials & methods
•	 We performed a cross-sectional study of subjects scheduled to undergo conventional MRI.
•	 Participants were asked to undergo additional 5–12 min of qMRI sequence after conventional MRI is 
performed. Post-menopausal status, age, hormone-replacement therapy and contraceptives use were 
recorded to perform stratification at data analysis. All images were obtained between days 5 and 10 of 
menstrual cycle in order to have consistency in MRI data.
•	 Images obtained with the mixed-turbo spin echo pulse sequence in the coronal plane of the entire breast were 
post-processed for generating T1 and T2 distributions, which were spatially co-registered. These were used as 
input for a T1/T2 ratio algorithm to distinguish between benign and malignant breast lesions.
•	 Descriptive statistical analysis and nonparametric analysis correlating T1/T2 ratio and the tumor grade was 
performed. The Wilcoxon scores for T1/T2 ratio were assigned based on rank sums that were performed for 
each group.
•	 We analyzed contralateral breast by qMRI and assessed T1/T2 ratios of glandular tissue as a control sample in 
all study groups. Correlations between T1/T2 ratios were made with histopathology findings and conventional 
MRI results.
Results
•	 Elevated T1/T2 means of 8.20 ± 1.05 (n = 12) were observed for biopsy-proven malignant lesions and 6.55 ± 
0.63 (n = 28) for malignant lesions that were treated prior to qMRI with chemotherapy and/or radiation as 
compared with 4.1 ± 0.43 (n = 29) for benign lesions.
•	 The T1/T2 ratios obtained by qMRI strongly correlate with histopathological findings. The nonparametric 
analysis revealed correlation between elevated T1/T2 ratio and more advanced disease stage.
•	 Overall, elevated T1/T2 ratios detected in primary cancer and post-treatment group were consistently higher 
than the ones observed in glandular control tissues, indicating that differences in T1/T2 ratio between 
examined groups, obtained post-gadolinium administration, were attributed to pathological changes in 
ductal or lobular breast tissues.
•	 We observed that early rapid enhancement after gadolinium administration on conventional MRI did correlate 
with elevated T1/T2 ratio (p = 0.0007).
Discussion
•	 We applied quantitative MRI relaxometry of T1/T2 ratio to study breast lesions with different histopathology. 
It provided a quantitative result and it produced high quality image on T1, T2 and T1/T2 maps, as tested on 69 
female subjects with 69 known or suspected lesions.
•	 We found statistically significant correlation between higher T1/T2 ratio and higher stage of breast cancer 
determined by histopathology, which is currently a standard for diagnosis of breast cancer.
•	 In addition, early rapid enhancement after gadolinium administration on conventional MRI did correlate with 
higher T1/T2 ratio obtained by qMRI (p = 0.0007). Therefore, there is a potential for complementary use of 
those two breast imaging techniques in future.
Conclusion & future perspective
•	 Quantitative MRI approach may provide valuable complementary information on different tissue properties to 
established breast imaging sequence as additional diagnostic tool which can possibly translate into improved 
diagnosis of breast cancer.
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